BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18157497)

  • 1. Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene.
    Xie LH; Sin FW; Cheng SC; Cheung YK; Chan KT; Xie Y; Xie Y
    Cancer Immunol Immunother; 2008 Jul; 57(7):1029-38. PubMed ID: 18157497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of CML28-specific cytotoxic T cell responses using co-transfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector.
    Zhou H; Zhang D; Wang Y; Dai M; Zhang L; Liu W; Liu D; Tan H; Huang Z
    Biochem Biophys Res Commun; 2006 Aug; 347(1):200-7. PubMed ID: 16815301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28.
    Han JF; Zhao TT; Liu HL; Lin ZH; Wang HM; Ruan ZH; Zou LY; Wu YZ
    Cancer Immunol Immunother; 2006 Dec; 55(12):1575-83. PubMed ID: 16534571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and expression of dendritic cell nucleic acid vaccine containing CML28 gene in human dendritic cells.
    Zhang DH; Zhou HS; Wang YY; Liu WL; Huang ZQ; Tan H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):631-6. PubMed ID: 16129049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
    Yang XF; Wu CJ; Chen L; Alyea EP; Canning C; Kantoff P; Soiffer RJ; Dranoff G; Ritz J
    Cancer Res; 2002 Oct; 62(19):5517-5522. PubMed ID: 12359762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer.
    Yu Y; Pilgrim P; Zhou W; Gagliano N; Frezza EE; Jenkins M; Weidanz JA; Lustgarten J; Cannon M; Bumm K; Cobos E; Kast WM; Chiriva-Internati M
    Viral Immunol; 2008 Dec; 21(4):435-42. PubMed ID: 19115932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells.
    Chan RC; Pang XW; Wang YD; Chen WF; Xie Y
    Br J Cancer; 2004 Apr; 90(8):1636-43. PubMed ID: 15083197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses.
    Cho HI; Kim HJ; Oh ST; Kim TG
    Vaccine; 2003 Dec; 22(2):224-36. PubMed ID: 14615150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene.
    Lin L; Wei J; Chen Y; Huang A; Li KK; Zhang W
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):281-9. PubMed ID: 24322180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells.
    Liu Y; Chiriva-Internati M; You C; Luo R; You H; Prasad CK; Grizzi F; Cobos E; Klimberg VS; Kay H; Mehta JL; Hermonat PL
    Cancer Gene Ther; 2005 Mar; 12(3):304-12. PubMed ID: 15565181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vector.
    Batchu RB; Gruzdyn OV; Moreno-Bost AM; Szmania S; Jayandharan G; Srivastava A; Kolli BK; Weaver DW; van Rhee F; Gruber SA
    Vaccine; 2014 Feb; 32(8):938-43. PubMed ID: 24406390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer.
    Lee HJ; Hong CY; Kim MH; Lee YK; Nguyen-Pham TN; Park BC; Yang DH; Chung IJ; Kim HJ; Lee JJ
    Exp Mol Med; 2012 Jan; 44(1):60-7. PubMed ID: 22089087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.
    Sui CG; Wu D; Meng FD; Yang MH; Jiang YH
    Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring CML28 mRNA levels in patients before and after HSCT by real-time quantitative RT-PCR].
    Zhang DH; Dai M; Zhou HS; Wang YY; Zhang L; Zhang L; Wang B; Cao WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):843-7. PubMed ID: 16277855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of the cytotoxic T lymphocyte response against hepatocellular carcinoma by transduction of cancer cells with an adeno-associated virus carrying the interferon-γ gene.
    Zhou J; Ma P; Li J; Cui X; Song W
    Mol Med Rep; 2016 Apr; 13(4):3197-205. PubMed ID: 26936017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.